Namwiwat Medical Corporation Valuation
Is NAM-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NAM-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NAM-F (THB4.94) is trading above our estimate of fair value (THB0.9)
Significantly Below Fair Value: NAM-F is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NAM-F?
Key metric: As NAM-F is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is NAM-F's PE Ratio? | |
|---|---|
| PE Ratio | 19.8x |
| Earnings | ฿167.99m |
| Market Cap | ฿3.32b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.5x |
| Enterprise Value/EBITDA | 10.6x |
| PEG Ratio | 1.2x |
Price to Earnings Ratio vs Peers
How does NAM-F's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 24.2x | ||
TOG Thai Optical Group | 12.3x | n/a | ฿4.8b |
LPH Ladprao General Hospital | 45.8x | n/a | ฿3.2b |
TRP Aesthetic Connect | 21.3x | 22.1% | ฿3.2b |
RPH Ratchaphruek Hospital | 17.3x | n/a | ฿3.0b |
NAM-F Namwiwat Medical Corporation | 19.8x | 16.9% | ฿3.3b |
Price-To-Earnings vs Peers: NAM-F is good value based on its Price-To-Earnings Ratio (19.8x) compared to the peer average (25.9x).
Price to Earnings Ratio vs Industry
How does NAM-F's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?
| 3 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: NAM-F is good value based on its Price-To-Earnings Ratio (19.8x) compared to the Asian Medical Equipment industry average (23.9x).
Price to Earnings Ratio vs Fair Ratio
What is NAM-F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 19.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NAM-F's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Master Style
฿12.7b
Operates a cosmetic surgery hospital under the Masterpiece Hospital name in Thailand.
MASTER
฿42.25
7D
-1.7%
1Y
-5.3%
E for L Aim
฿1.1b
Engages in the distribution of medical devices and equipment in Thailand.
EFORL-R
฿0.28
7D
3.7%
1Y
12.0%
Safe Fertility Group
฿3.6b
Provides fertility medical center services in Thailand.
SAFE
฿12.00
7D
-0.8%
1Y
-33.0%